구강 편평세포암종 세포주에서 Cyclosporin A와 Taxol 투여시 PI-3 kinase/Akt1 Pathway에 의한 세포사멸 병용효과

참고문헌 (76)

1. "Decreased cisplatin uptake by resistant L1210 leukemia cells"
2. "Failure at the primary site-following multimodality treatment for advanced head and neck cancer"
3. "Endocrine potentiation of the breakdown of the intersegmental muscles of silkmoths", pp.643~649
4. "Experimental & Molecular medicine", 33, pp.83~93
5. "Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression", 266(2), pp.504~511 (1996)
6. "Induction of apoptosis by cancer chemotherapy", 256(1), pp.42~49 (2000)
7. "Inactivation of Bcl-2 by phosphorylation", 92(10), pp.4507~4511 (1995)
8. "Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal Kinase(JNK)-dependent and independent pathways in ovarian cancer cell", 19(274), pp.8208~8216 (1999)
9. "Induction of caspase -3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel", 357(1), pp.65~73 (2005)
10. "Taxol Induces Caspase-10-dependent Apoptosis", 279(49), pp.51057~51067 (2004)
11. "Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death", 56(4), pp.816~825 (1996)
12. "Taxol suppresses dynamics of individual microtubules in living human tumor cells", 10(4), pp.947~959 (1999)
13. "Mechanisms of action of cyclosporine", 47, pp.119~125 (2000)
14. "Effect of cyclosporin A on the T-effector and Tsuppressor cell response in contact sensitivity", pp.503~511
15. "Induction of apoptosis in murine lymphoma cells by cyclosporin A", 7(4), pp.431~437 (2001)
16. "Apoptosis and necrosis : mechanisms of cell death induced by cyclosporine A in a renal proximal tubular cell line", 54(6), pp.1955~1966 (1998)
17. "Intracellular mechanisms cyclosporin A-induced tubular cell apoptosis", 14(12), pp.3072~3080 (2003)
18. "Cyclosporine A induces growth arrest or programmed cell death of human glioma cells", 47(6), pp.430~441 (2005)
19. "Anti-cancer effect of Cyclosporin A on oral squamous cell carcinoma cell line", 30(06), pp.474~481 (2004)
20. "Coadministration of oral cyclosporin A enables oral therapy with paclitaxel", 5, pp.3379~3384 (1999)
21. "P-glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances bioavailability and antitumor efficacy of orally administered paclitaxel", 49(4), pp.322~328 (2002)
22. "Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel", 19(4), pp.1160~1166 (2001)
23. "Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice", 17(1), pp.7~14 (2004)
24. "Reversal of Taxol resistance in hepatoma by cyclosporin A : involvement of the Pl-3 Kinase-Akt 1 pathway", 88, pp.973~980 (2003)
25. "Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK", PKB) promoted by serum and protein phosphatase inhibitors, 1996, pp.93(12), 5699~5704
26. "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery", 91(2), pp.231~241 (1997)
27. "Aging is associated with decreased pancreatic acinar cell regeneration and phosphatidylinositol 3-kinase", Akt activation, 2005, pp.128(5), 1391~1404
28. "Phosphoinositide 3-Kinase", Akt1 Pathway and Human Ovarian Cancer SEP 2002, ~
29. "The phosphoinositide 3-kinase", Akt1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells, 2003, pp.1(3), 234~246
30. "The adenomatous polyposis coli (APC) tumor suppressor", 1332(3), pp.F127~F147 (1997)
31. "Why is everything so negative?", 10(2), pp.182~187 (1998)
32. "Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6", Arrow, 2001, pp.3(7), 683~686
33. "Inhibition of Wnt Signaling Downregulates Akt Activity and Induces Chemosensitivity in PTEN-Mutated Prostate CancerCells Prostate", 62, pp.61~68 (2005)
34. "life as a tumor suppressor", 264, pp.29~41 (2001)
35. "A new mouse model of pancreatic cancer: PTEN gets its Akt together", 8(3), pp.171~172 (2005)
36. "PTEN", MMAC1, pp.1999, 263[DOI]
37. "LDL-receptor-related proteins in Wnt signal transduction", 407(6803), pp.530~535 (2000)
38. "Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis", 94(4), pp.491~501 (1998)
39. "An informatics approach identifying markers of chemosensitivity in human cancer", 60, pp.6101~6110 (2000)
40. "Prosmise and problem of Bcl-2 antisene therapy", 89, pp.988~990 (1997)
41. "Bcl-2 is the guardian of microtubule integrity", 57, pp.229~233 (1997)
42. "Phosphoinositide 3-kinase(PI3-K) expression. Tumorigenesis of epithelial carcinoma of the mouth", 25(1), pp.31~37 (2004)
43. "The PI3K", PTEN, pp.2003, 115[DOI]
44. "The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signalling", 1470, pp.M21~M35 (2000)
45. "The regulation and activities of the multi-functional serine", threonine kinase Akt, pp.1999, 253[DOI]
46. "PI3-kinase inhibition : a target for drug development?", 6, pp.347~357 (2000)
47. "Signaling by distinct classes of phosphoinositide 3-kinases", 253, pp.239~254 (1999)
48. "Cellular survival : a play in three Akts", 13(22), pp.2905~2927 (1999)
49. "Akt-dependent transformation : there is more to growth than just surviving", 24(50), pp.7435~7442 (2005)
50. "Phosphorylation and regulation of Raf by Akt(protein kinase B)", 286(5445), pp.1741~1744 (1999)
51. "Microtubule stabilizing agents: Their molecular signaling consequences and the potential for enhancement by drug combination Cancer Treatment Reviews", 32, pp.166~179 (2000)
52. "The Akt", PKB pathway: molecular target for cancer drug discovery, 2005, pp.24(50), 7482~7492
53. "Inactivation of the antiapoptotic phosphatidylinositol 3-kinase-Akt pathway by the combined treatment of Taxol and mitogen-activated protein kinase inhibition", 8(7), pp.2091~2099 (2002)
54. "Inhibition of phosphatidylinositol 30-kinase increases efficacy of paclitaxel in vitro and in vivo ovarian cancer models", 62(4), pp.1087~1092 (2002)
55. "Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoin- ositide 3-kinase inhibitor in human malignant glioma cells", 63(14), pp.4044~4047 (2003)
56. "In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin", 15, pp.1135~1139 (1995)
57. "The phosphatidylinositol 3-kinase inhibitor wortmannin sensitises murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage", 56, pp.246~250 (1996)
58. "Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of recept or-directed-toxin chimeras in vitro and in vivo", 19, pp.1705~1713 (1999)
59. "Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase", 44, pp.491~497 (1999)
60. "Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01", 15(10), pp.4029~4037 (2004)
61. "Phosphatidylinositol 3-kinases in tumor progression", 268, pp.487~498 (2001)
62. "Deficiency of pten accelerates mammary oncogenesis in MMTV-Wnt-1 transgenic mice" (2001)
63. "PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase", Akt-dependent and -independent pathways, 2001, pp.10, 237~242
64. "ANNEXIN V in “Purdue Cytometry CD-ROM Series", me 4”, University“ La Sapienza”
65. "A novel assay for apoptosis Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V", pp.39~51 (1995)
66. "The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents", 48, pp.353~374 (1997)
67. "Channel formation by antiapoptotic protein Bcl-2", 13(94), pp.5113~5118 (1997)
68. "Signalling and activation of Forkhead are indispensable for upregulation of FasL expression in apoptosis of glioma cell", 23(22), pp.7616~7627 (2003)
69. "Disruption of mitochondrial membrane potential during apoptosis induced by Psc 833 and CsA in multidrug resistant lymphoid leukemia", pp.44~51
70. "Cyclosporin A and Fk506 induce osteoclast apoptosis in mouse bone marrow cell cultures", 35(1), pp.47~56 (2004)
71. "Phase II and pharmacologic study of weakly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer", 20(23), pp.4508~4516 (2002)
72. "Enhancement by cyclosporin A of taxol-indeced apoptosis of human urinary bladder cancer cells", 30(2), pp.102~111 (2002)
73. "Increased penetration of paclitaxel into the brain by inhibition of P-glycoprotein", 9(7), pp.2849~2855 (2003)
74. "Efficacy of novel p-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice", 22(3), pp.219~229 (2004)
75. "Mechanism of Taxol-induced cell death are concentration dependent", 58, pp.3620~3626 (1998)
76. "Mechanism of Taxol-induced cell death are concentration dependent", 58, pp.3620~3626 (1998)

관련 논문AI추천